Acute renal colic: Beyond kidney stones  by Silva, Sandra et al.
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me. Muscle necrosis has been described following treatment
ith both drugs.5,6 Between 15 and 33% of patients develop
KI.7 Up to 37% of them require haemodialysis. Mortality is
, although it rises to 25% when complicated by AKI.
The mechanism of muscle toxicity is not fully understood.
tatins may interfere in the synthesis of the Q10 coenzyme
oQ10 or ubiquinone) involved in energy production of mus-
e cells.8
Muscular symptoms usually start weeks or months after
e initiation of treatment, but just as in our patient, it may
ccur at any time. In a series including 44 patients, mean
eatment duration before symptoms was 6.3 months (range:
25–48). Symptoms resolved following drug withdrawal after
mean of 2.3 months (range: 0.25–14).9
Also important is the fact that the patient was taking the
llowing drugs: a non-steroid anti-inﬂammatory drug, an
giotensin receptor antagonist, and a diuretic. This combi-
4. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum
CB,  Eckel RH, et al. 2013 ACC/AHA guideline on the treatment
of  blood cholesterol to reduce atherosclerotic cardiovascular
risk in adults: a report of the American College of
Cardiology/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol. 2014;63:
2889–934.
5. Chang CH, Kusama M, Ono S, Sugiyama Y, Orii T, Akazawa M.
Assessment of statin-associated muscle toxicity in Japan: a
cohort study conducted using claims database and laboratory
information. BMJ Open. 2013;3, pii: e002040.
6. Martínez-López D, Enríquez R, Sirvent AE, Redondo-Pachón
MD, Millán I, Amorós F. Rabdomiólisis y fracaso renal agudo
tras trabajo intenso en un paciente en tratamiento con
rosuvastatina. Nefrologia. 2012;32:127–8.
7. Oshima Y. Characteristics of drug associated rhabdomyolysis:
analysis of 8,610 cases reported to the U.S. Food and Drug
Administration. Intern Med. 2011;50:845–53.
8. Rundek T, Naini A, Sacco R, Coates K, DiMauro S. Atorvastatination is sometimes referred to as a “Triple whammy” and
10
decreases the coenzyme Q10 level in the blood of patients at
risk for cardiovascular disease and stroke. Arch Neurol.
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cálculos  renalesas been associated with a higher incidence of AKI. In our
atient, other drugs may have led to decreased GFR and the
evelopment of muscle necrosis.
In summary, our case highlights the need for a thorough
sessment of the risk-beneﬁt proﬁle when prescribing drugs
 elderly patients with CKD, which should be staged based on
e measurement of GFR. Statin-associated rhabdomyolysis
ay occur at any time of the disease course, while concomi-
nt use with certain drugs may increase toxicity.
e  f  e  r  e  n  c  e  s
. Torres PA, Helmstetter JA, Kaye AM, Kaye AD.
Rhabdomyolysis: pathogenesis, diagnosis, and treatment.
Ochsner J. 2015;15:58–69.
. Stevens PE, Levin A, Kidney Disease: Improving Global
Outcomes Chronic Kidney Disease Guideline Development
Work  Group Members. Evaluation and management of
chronic kidney disease: synopsis of the kidney disease
improving global outcomes 2012 clinical practice guideline.
Ann Intern Med. 2013;158:825–30.
. Martínez-Castelao A, Górriz JL, Bover J, Segura-de la Morena J,
Cebollada J, Escalada J, et al. Documento de consenso para la
detección y manejo de la enfermedad renal crónica.
Nefrologia. 2014;34:243–62.
cute  renal  colic:  Beyond  kidne
ólico  renal  agudo:  más  allá  de  los  ear Editor,
 59-year-old woman  without relevant past medical history
resented with hematuria and renal colic. After a negative
iagnostic work-up, sickling vaso-occlusive crisis in the set-
ng of sickle cell trait (SCT) was diagnosed. This report aims to
ise awareness that SCT should be included in the differential
iagnosis of unexplained hematuria and/or renal colic.
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stonesRenal abnormalities are frequently described in patients
ith sickle hemoglobinopathies, but SCT patients (heterozy-
us carriers, with one sickle cell gene and one normal gene)
e mostly asymptomatic.1 However sickle cell crisis can occur
 the patient is exposed to hypoxic conditions, high alti-
de and intense physical exercise.1 Acute events include
so-occlusive crises such as papillary necrosis of the kidney,
chemic stroke and infections.2
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A 59-year-old Caucasian woman presented with dark-
red urine and colicky pain in the left ﬂank. She had no
fever, dysuria, urinary urgency and no history of trauma,
nephrolithiasis or additional episodes of hematuria. She
was of Asian ascendancy and had non-consanguineous par-
ents. Her medical history was unremarkable, except for
hypertension. Her chronic medication consisted of can-
desartan/hydrochlorothiazide and she denied non-steroidal
anti-inﬂammatory drugs use.
Physical examination revealed modest overweight,
blood pressure of 110/60 mmHg, no evidence of hep-
atosplenomegaly, although left costovertebral tenderness
was noted.
Laboratory tests showed normal blood cell counts, coagu-
lation parameters, electrolytes, and renal and hepatic tests.
No rhabdomyolysis nor hemolysis were present. Urine dip-
stick revealed a speciﬁc gravity of 1.010, 3+ hemoglobin and
no protein; the microscopic exam showed 168 red blood cells
per high power ﬁeld, but no casts or white blood cells. Urine
cultures, including for mycobacteria, were negative. She had
no anomalous cells in cytology and a normal cystoscopy. A
computed tomography scan (Fig. 1A–C) suggested renal pap-
illary necrosis and excluded other abnormalities. There were
no criteria for diabetes mellitus. Hemoglobin’s electrophoresis
showed the presence of an abnormal hemoglobin (Fig. 2) which
was subsequently documented to be HbS. A molecular study
revealed an heterozygosity for the hemoglobin sickle mutation
of the -globin gene (HBB:c.20A>T) establishing a diagnosis of
SCT.
Clinical ﬁndings resolved after conservative therapy
with rest, hydration and analgesia. The patient was rec-
ommended to avoid circumstances that may precipitate
vaso-occlusive crises. Her daughter was referred for genetic
testing.
SCT is generally asymptomatic, although occasionally
associated with signiﬁcant morbidity, including papillary
necrosis.1 It is a highly prevalent recessive illness, mainly
found in African but also in Asian populations.3 In SCT
patients, HbS is abnormally found with plasma concentrations
typically between 35% and 45% of total hemoglobin.4
Hematuria is the most common complication1 of SCT, but
the usual etiologies, such as stones, urinary tract infections
or neoplasms should be considered ﬁrst. Hence, initial test-
ing must include urine analysis, culture, cytology and imaging
studies. In SCT patients, occlusion of small vessels by sickled
blood cells, causes microthrombi and ischaemia.2 In the kid-
neys, this obstruction is predominantly apparent in the renal
papilla due to their marginal blood supply. Papillary necrosis
can be difﬁcult to diagnose. The presence of sloughed papillae
in the urine examination is diagnostic, but has low sensitivity.5
In our patient an ultrasound and a tomography scan allowed
the diagnosis. Treatment is usually conservative, but adjuvant
therapies (desmopressin or epsilon-amino caproic acid) can be
of beneﬁt.1 Most severe cases may require arterial emboliza-
tion or surgical exploration. The outcome is generally good but
the patient must be informed about avoidable precipitating
Fig. 1 – A, B, C: Sagital, coronal and axial sections of
abdominal computed tomography revealing structural
heterogeneity of the left renal parenquima with diminished
enhancement at the tip of the medullary pyramid and the
presence of small cavities ﬁlled by contrast on the borders
of the small calices – aspects highly suggestive of papillary
necrosis ischemia.conditions and genetic counseling.2
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of glucose.1 Over 80% of cases have been described in diabetic
patients. Urinary tract obstruction is a major risk factor of EPN,
and women are affected more  often in a 4:1 ratio.2 Mortal-
ity from EPN is primarily attributable to septic complications,
with almost 78% of cases reported by the late 1970s. However,
the improvement in management techniques has reduced this
ﬁgure to 21% over the last two decades.3
The clinical course of EPN is typically severe and rapidly
progresses to sepsis with multiple organ failures. CAT scans
are considered the gold standard for diagnosis and staging.184  n e f r o l o g i a. 2 0
Hemoglobin fractions:
• HbA1 - 57 %
• HbS - 40 %
• HbA2 -  3 %
*
g. 2 – Hemoglobin electrophoresis (cellulose acetate):
mino acids substitution in hemoglobin variants alter
arge and subsequently hemoglobin’s mobility pattern.
resence of an abnormal hemoglobin variant in Z5 region,
mpatible with HbS (*).
Hemoglobin’s electrophoresis should be part of the diag-
ostic work-up of renal colic and/or hematuria, namely in
atients whose etiology has never been established.
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physematous pyelonephritis (EPN) is a rare necrotizing
ndition of the kidney, and is particularly rare in renal trans-
lant recipients. It is characterized by the presence of gas in
e renal parenchyma, the perirenal space, or the urinary tract
 a result of an infection. Infection is generally caused by gas-
roducing microorganisms, including Escherichia coli (over 80%
f cases) or Klebsiella pneumoniae, due to mixed fermentationPlease cite this article as: Hernández-Vargas H, Sierra-Carpio M, Gil-Catalinas F, Bello-Ovalle A, Beired-Val I, Pimentel-Guzmán GI, et al.
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